Clinical Report: Mass Spec Roundup: Hidden Signals and Sharper Reads

Background

The ability to accurately identify and quantify low-abundance lipids and peptides is crucial in various clinical and research settings. Plasmalogens, a class of phospholipids, have been implicated in several diseases.

Data Highlights

No numerical data available in the source material.

Key Findings

• Targeted nano-DESI tandem mass spectrometry imaging successfully resolved 38 plasmalogen species in mouse brain tissue.
• The workflow distinguished lipids with nearly identical masses, preserving spatial information while reducing interference from higher-abundance isobars.
• A new N-terminal tagging method improved de novo sequencing of short peptides, achieving complete identification of 132 peptide standards without misidentification.
• Short peptides identified using the new method showed a fivefold increase in tripeptide identifications compared to conventional analysis.
• The fentanyl vaccine developed demonstrated the ability to generate broadly cross-reactive antibodies despite structural differences from fentanyl.

Clinical Implications

Advancements in mass spectrometry techniques can enhance the understanding of lipid distributions in the brain. Improved peptide sequencing methods may facilitate better characterization of proteins in various biological samples.

Conclusion

The innovations in mass spectrometry presented in this report highlight significant progress in lipid and peptide analysis.

Related Resources & Content

1. the analytical scientist, Mass Spec Roundup: Molecules, Messages and Fingermarks, 2026 -- Mass Spec Roundup: Molecules, Messages and Fingermarks
2. the analytical scientist, Mass Spec Roundup: Peptides, Particles, Clocks, and Canines, 2026 -- Mass Spec Roundup: Peptides, Particles, Clocks, and Canines
3. the analytical scientist, Mass Spec Roundup: Speed, Scale, and Sharper Spectra, 2026 -- Mass Spec Roundup: Speed, Scale, and Sharper Spectra
4. the analytical scientist, Mass Spec Roundup: Proteins, Lipids, Pitcher Plants, and Coffee, 2026 -- Mass Spec Roundup: Proteins, Lipids, Pitcher Plants, and Coffee
5. Alzheimer's Association Clinical Practice Guideline on the use of blood‐based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings - Palmqvist - 2025 - Alzheimer's & Dementia - Wiley Online Library -- Alzheimer's Association Clinical Practice Guideline
6. Plasmalogens as biomarkers and therapeutic targets - Journal of Lipid Research -- Plasmalogens as biomarkers and therapeutic targets
7. Standard Addition as a Method for Quantitative Mass Spectrometry Imaging | Analytical Chemistry -- Standard Addition as a Method for Quantitative Mass Spectrometry Imaging
8. Alzheimer's Association Clinical Practice Guideline on the use of blood‐based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings - Palmqvist - 2025 - Alzheimer's & Dementia - Wiley Online Library
9. Plasmalogens as biomarkers and therapeutic targets - Journal of Lipid Research
10. Standard Addition as a Method for Quantitative Mass Spectrometry Imaging | Analytical Chemistry